Long-term Outcomes and Risk Factors After Adult Living Donor Liver Transplantation

被引:15
|
作者
Imai, Daisuke [1 ]
Yoshizumi, Tomoharu [1 ]
Sakata, Kazuhito [1 ]
Ikegami, Toru [1 ]
Itoh, Shinji [1 ]
Harada, Noboru [1 ]
Motomura, Takashi [1 ]
Toshima, Takeo [1 ]
Mano, Yohei [1 ]
Soejima, Yuji [1 ]
Maehara, Yoshihiko [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka, Japan
关键词
BILIARY ANASTOMOTIC STRICTURE; RECURRENT HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; A2ALL COHORT; COMPLICATIONS; RECIPIENTS; CRITERIA; MANAGEMENT; SELECTION; IMPACT;
D O I
10.1097/TP.0000000000002324
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Although risk factors for the long-term mortality of liver transplantation are well described, there is a lack of detailed study regarding these factors for adult living donor liver transplantation (LDLT). Methods We retrospectively analyzed 528 adult LDLT recipients in our hospital. The risk factors were analyzed for overall deaths more than 5 years post-LDLT. Results Over the 20-year follow-up, 137 patients died. Patient survival at 1, 3, 5, and 10 years post-LDLT was 87.8%, 81.8%, 79.4%, and 72.8%, respectively. The independent risk factors for more than 5 years post-LDLT overall death were hepatocellular carcinoma recurrence (hazard ratio [HR], 38.9; P < 0.001), lymphoid de novo malignancy (HR, 47.2; P = 0.001), primary sclerosing cholangitis as primary diagnosis (HR, 11.5; P < 0.001), chronic rejection (HR, 6.93; P = 0.006), acute rejection (HR, 2.96; P = 0.017), and bile duct stenosis (HR, 2.30; P = 0.045). Conclusions Not only malignancies and rejection but also bile duct stenosis and primary sclerosing cholangitis had significant impacts on late period post-LDLT mortality.
引用
收藏
页码:E382 / E391
页数:10
相关论文
共 50 条
  • [31] Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation
    Yao, Siyuan
    Yagi, Shintaro
    Nagao, Miki
    Uozumi, Ryuji
    Iida, Taku
    Iwamura, Sena
    Miyachi, Yosuke
    Shirai, Hisaya
    Kobayashi, Atsushi
    Okumura, Shinya
    Hamaguchi, Yuhei
    Masano, Yuuki
    Kaido, Toshimi
    Okajima, Hideaki
    Uemoto, Shinji
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (10) : 1973 - 1982
  • [32] The Causes, Risk Factors, and Outcomes of Early Relaparotomy After Living Donor Liver Transplantation
    Yoshiya, Shohei
    Shirabe, Ken
    Soejima, Yuji
    Yoshizumi, Tomoharu
    Uchiyama, Hideaki
    Ikegami, Toru
    Yamashita, Yo-ichi
    Harimoto, Norifumi
    Toshima, Takeo
    Maehara, Yoshihiko
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S1032 - S1032
  • [33] Long-term Outcomes of Pediatric Living Donor Liver Transplantation Using Pure Laparoscopic Donor Hepatectomy
    Kim, W. -J.
    Kim, S. -H.
    Kang, W. -H.
    Kwon, J. -H.
    Jwa, E. -K.
    Cho, H. -D.
    Ha, S. -M.
    Chung, Y. -K.
    Kim, K. -H.
    Lee, S. -G.
    [J]. TRANSPLANTATION, 2017, 101 (05) : 210 - 210
  • [34] Long-Term Outcomes for 32 Cases of Wilson's Disease After Living-Donor Liver Transplantation
    Yoshitoshi, Elena Y.
    Takada, Yasutsugu
    Oike, Fumitaka
    Sakamoto, Seisuke
    Ogawa, Kohei
    Kanazawa, Hiroyuki
    Ogura, Yasuhiro
    Okamoto, Shinya
    Haga, Hironori
    Ueda, Mikiko
    Egawa, Hiroto
    Kasahara, Mureo
    Tanaka, Koichi
    Uemoto, Shinji
    [J]. TRANSPLANTATION, 2009, 87 (02) : 261 - 267
  • [35] Short Term Donor Outcomes After Hepatectomy in Living Donor Liver Transplantation
    Dar, Faisal Saud
    Zia, Haseeb
    Bhatti, Abu Bakar Hafeez
    Rana, Atif
    Nazer, Rashid
    Kazmi, Rubab
    Khan, Etizaz-ud-Din
    Khan, Nasir Ayub
    Salih, Muhammad
    Shah, Najmul Hassan
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2016, 26 (04): : 272 - 276
  • [36] The Impact of Donor Specific Antibodies on the Long-Term Liver Allograft after Pediatric Living Donor Liver Transplantation
    Yoshizawa, A.
    Yurugi, K.
    Hishida, R.
    Miyagawa-Hayashino, A.
    Haga, H.
    Maekawa, T.
    Uemoto, S.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 379 - 379
  • [37] The Impact of Donor Specific Antibodies on the Long-Term Liver Allograft after Pediatric Living Donor Liver Transplantation
    Yoshizawa, A.
    Yurugi, K.
    Hishida, R.
    Miyagawa-Hayashino, A.
    Haga, H.
    Maekawa, T.
    Uemoto, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 239 - 239
  • [38] Risk factors for graft dysfunction after adult-to-adult living donor liver transplantation.
    Marubashi, S
    Dono, K
    Sakon, M
    Takahashi, H
    Hashimoto, K
    Kubota, M
    Yamamoto, S
    Nakano, H
    Nakamori, S
    Umeshita, K
    Monden, M
    [J]. LIVER TRANSPLANTATION, 2004, 10 (06) : C56 - C56
  • [39] Risk factors for graft dysfunction after adult-to-adult living donor liver transplantation.
    Marubashi, S
    Dono, K
    Takahashi, H
    Gotoh, K
    Hashimoto, K
    Kubota, M
    Miyamoto, A
    Nagano, H
    Nakamori, S
    Umeshita, K
    Sakon, M
    Monden, M
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 295 - 295
  • [40] LONG-TERM OUTCOME AFTER LIVING DONOR LIVER TRANSPLANTATION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Miyagawa, Shinichi
    Ikegami, Toshihiko
    Nakazawa, Yuuichi
    Urata, Kouichi
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S129 - S129